Search Results - "Weissbrich, Bianca"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1
  2. 2
  3. 3

    Flow cytometry‐based TCR‐ligand K off ‐rate assay for fast avidity screening of even very small antigen‐specific T cell populations ex vivo by Nauerth, Magdalena, Stemberger, Christian, Mohr, Fabian, Weißbrich, Bianca, Schiemann, Matthias, Germeroth, Lothar, Busch, Dirk H.

    Published in Cytometry. Part A (01-09-2016)
    “…Abstract High epitope‐specific sensitivity of CD8 + T cells is required for optimal immune protection against intracellular pathogens as well as certain…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Disparate Individual Fates Compose Robust CD8⁺ T Cell Immunity by Buchholz, Veit R., Flossdorf, Michael, Hensel, Inge, Kretschmer, Lorenz, Weissbrich, Bianca, Gräf, Patricia, Verschoor, Admar, Schiemann, Matthias, Höfer, Thomas, Busch, Dirk H.

    “…A core feature of protective T cell responses to infection is the robust expansion and diversification of naïve antigen-specific T cell populations into…”
    Get full text
    Journal Article
  8. 8

    Engineered T cells targeting E7 mediate regression of human papillomavirus cancers in a murine model by Jin, Benjamin Y, Campbell, Tracy E, Draper, Lindsey M, Stevanović, Sanja, Weissbrich, Bianca, Yu, Zhiya, Restifo, Nicholas P, Rosenberg, Steven A, Trimble, Cornelia L, Hinrichs, Christian S

    Published in JCI insight (19-04-2018)
    “…T cell receptor (TCR) T cell therapy is a promising cancer treatment modality. However, its successful development for epithelial cancers may depend on the…”
    Get full text
    Journal Article
  9. 9

    Flow cytometry‐based TCR‐ligand Koff‐rate assay for fast avidity screening of even very small antigen‐specific T cell populations ex vivo by Nauerth, Magdalena, Stemberger, Christian, Mohr, Fabian, Weißbrich, Bianca, Schiemann, Matthias, Germeroth, Lothar, Busch, Dirk H.

    Published in Cytometry. Part A (01-09-2016)
    “…High epitope‐specific sensitivity of CD8+ T cells is required for optimal immune protection against intracellular pathogens as well as certain malignancies…”
    Get full text
    Journal Article
  10. 10

    The common HLA class I-restricted tumor-infiltrating T cell response in HPV16-induced cancer by Santegoets, Saskia J., Welters, Marij J. P., Schrikkema, Deborah S., Freriks, Manon R., Kok, Hanna, Weissbrich, Bianca, van den Branden, Anouk, Linnemann, Carsten, Schumacher, Ton N., Adhikary, Sabina, Bendle, Gavin, van der Burg, Sjoerd H.

    Published in Cancer Immunology, Immunotherapy (01-06-2023)
    “…Immunotherapies targeting truly tumor-specific targets focus on the expansion and activation of T cells against neoantigens or oncogenic viruses. One target is…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Adoptive immunotherapy: New assay for the identification of T cells with optimal avidity by Weissbrich, Bianca, Nauerth, Magdalena, Busch, Dirk H

    Published in Oncoimmunology (01-10-2013)
    “…T cells expressing high avidity T-cell receptors (TCRs) have been shown to mediate superior therapeutic effects. A novel k off -rate assay allows for the…”
    Get full text
    Journal Article
  14. 14
  15. 15